Table of contents
- Preliminary material (229KB PDF)
- Title and verso pages
- Contents
- Acknowledgments
- Abbreviations
- Summary
- Clients
- Drugs
- Treatment
- Agencies
- Body section (322KB PDF)
- Introduction
- 1.1 Purpose and structure
- 1.2 Scope of the AODTS-NMDS
- 1.3 Collection count
- 1.4 Data issues
- 1.5 Other information from the AODTS-NMDS collection
- Treatment agency profile
- 2.1 Treatment agency sector
- 2.2 Location of treatment agencies
- 2.3 Location of treatment agencies and treatment types
- Client profile
- 3.1 Client type
- 3.2 Age and sex
- 3.3 Indigenous status
- 3.4 Country of birth and preferred language
- Drugs of concern
- 4.1 Context
- 4.2 Principal drug of concern
- 4.3 All drugs of concern
- 4.4 Alcohol
- 4.5 Cannabis
- 4.6 Amphetamines
- 4.7 Heroin
- 4.8 Benzodiazepines
- 4.9 Ecstasy
- 4.10 Cocaine
- Treatment programs
- 5.1 Main treatment
- 5.2 Additional treatments
- 5.3 Counselling
- 5.4 Withdrawal management (detoxification)
- 5.5 Assessment only
- 5.6 Information and education only
- 5.7 Support and case management only
- 5.8 Rehabilitation
- 5.9 Other main treatment types
- 5.10 National Opioid Pharmacotherapy Statistics Annual Data Collection 2008
- Collection methods and data quality
- 6.1 Collection method and data included
- 6.2 Comprehensiveness of the data
- 6.3 Data quality
- Data development-enhancing policy and planning relevance
- 7.1 How much treatment is being provided?
- 7.2 Is treatment accessible?
- 7.3 Is treatment effective?
- Introduction
- End matter (309KB PDF)
- Appendixes
- 2007-08 data elements
- Policy and administrative features in each jurisdiction
- Detailed tables
- Australian Standard Geographical Classification
- Australian Standard Classification of Drugs of Concern
- Alcohol and other drug treatment provided by services funded to assist Aboriginal and Torres Strait Islander peoples
- Mapping of ICD-10-AM codes to ASCDC output categories
- References
- List of tables
- List of figures
- List of boxes
- Appendixes